Tag Archives: Cancer

AMP 2015 in Review

It was great attending AMP. We not only announced enhancements to our QIAGEN Clinical Insight (QCI™) solution, but we also met new friends and customers, learned about fascinating new studies, and interacted with many brilliant minds in the field of molecular … Read More

Posted in Events, News | Tagged , , , , , ,

Launch of QIAGEN Clinical Insight for Hereditary Cancer

Simple, secure, and scalable interpretation workflow We are delighted to announce that we’ve expanded our QIAGEN® Clinical Insight™ (QCI™) solution to address the NGS interpretation and reporting needs of clinicians in oncology labs around the globe. For germline cancers, we introduce the … Read More

Posted in News, Products | Tagged , , , , , Product

UC Davis Scientists Spot Mutations in Circulating Tumor DNA with Ingenuity Variant Analysis

As Technical Director of the Genomics Shared Resource at the University of California, Davis, Comprehensive Cancer Center, Cliff Tepper routinely faces a series of challenges: monitoring new technologies; adapting platforms for translational use; interrogating a broad array of cancers; and … Read More

Posted in Customer Stories | Tagged , , , , , , , , , Product

AACR 2015: Looking Forward to Philly

Later this week we’ll be heading to the annual meeting of the American Association for Cancer Research (AACR 2015), held this year April 18-22 at the massive Pennsylvania Convention Center in Philadelphia. AACR is a master class for the most … Read More

Posted in Events, News | Tagged , , , Product

Doug Bassett Talks Data Interpretation with Front Line Genomics

Data interpretation was a big topic of discussion at this year’s ASHG meeting, especially as it relates to translational research and clinical applications. The program was packed with population studies, cancer studies, and other massive-scale hunts for causal variants driving … Read More

Posted in Events | Tagged , , , , , , Product ,

Clinical Lab Director’s View Part 2: Scoring a Variant

In this blog miniseries, we’ve asked Junaid Shabbeer, Clinical Science Director at QIAGEN Bioinformatics, to guide us through the process of analyzing DNA variants for genetic tests. In our last post we walked through what it takes to launch a … Read More

Posted in Products | Tagged , , , , , , , , Product

Mount Sinai Scientists Find Novel Ovarian Cancer Biomarker with IPA

Treatment options for ovarian cancer haven’t changed much in three decades — but a powerful new biomarker identified by scientists at Mount Sinai has shed light on why some patients respond well to the gold-standard chemotherapy regimen while others do … Read More

Posted in News | Tagged ,

NGS-Based Cancer Tests Reveal Limitations of Manual Variant Analysis

As we work with our early access partners to put the finishing touches on QIAGEN’s Ingenuity Clinical web application for DNA sequence variant interpretation in clinical labs, we sat down with Junaid Shabbeer, the new clinical science director here at … Read More

Posted in Products | Tagged , , , Product